The CDC and FDA temporarily paused the use of the Johnson & Johnson COVID vaccine to study the cases of 15 people (out of nearly 8 million) who developed a rare type of blood clot after receiving the vaccine. They have concluded that the risk of blood clots is extremely rare and the benefits of receiving the vaccine far outweigh any risks. Therefore, the CDC and FDA have approved resuming the use of the Johnson & Johnson vaccine. However, patients who receive the vaccine should be alert for symptoms including persistent, severe headaches, blurred vision, shortness of breath, chest pain, leg swelling, persistent abdominal pain or unusual bruising. If you develop any of these symptoms within three weeks after vaccination, contact your Maryland Primary Care Physicians provider.
Author Archives: Trudy
eNewsletter Spring 2021 – Covid ‘Long Haulers,’ Allergy Season & More
|
|
|
|
|
|
|
|
|
|
The Queenstown Office Now Offers Diabetic Retinopathy Screening to Patients with Type I or Type II Diabetes
Diabetic Retinopathy is the most common diabetic eye disease and can lead to vision loss, but early detection may help reduce the severity of the disease. All people with diabetes, Type 1 or Type 2, are at risk for diabetic retinopathy. To identify problems, diabetics should have yearly eye exams/screenings as a part of your diabetes management. We are now offering the screening for Diabetic Retinopathy in office. Please schedule your appointment today.
The Pasadena Office Now Offers Diabetic Retinopathy Screening to Patients with Type I or Type II Diabetes
Diabetic Retinopathy is the most common diabetic eye disease and can lead to vision loss, but early detection may help reduce the severity of the disease. All people with diabetes, Type 1 or Type 2, are at risk for diabetic retinopathy. To identify problems, diabetics should have yearly eye exams/screenings as a part of your diabetes management. We are now offering the screening for Diabetic Retinopathy in office. Please schedule your appointment today.
